FDA expands availability of abortion pills

Washington — The Food and Drug Administration on Tuesday finalized a rule change that broadens availability of abortion pills to many more pharmacies, including large chains and mail-order companies. The Biden administration partially implemented the change last year, announcing it would no longer enforce a long-standing requirement that women pick up the medicine in person. … Read more

FDA urges parents not to stockpile children’s flu medications

The surge in flu cases and Covid-19 infections this month, along with elevated levels of childhood respiratory syncytial virus, or RSV, infections has caused elevated demand for children’s over-the-counter cold and flu medications. The commissioner of the Food and Drug Administration said his agency is working with producers to improve supply but the current demand … Read more

FDA changes Plan B packaging to clarify that it is not an abortion pill

In this photo illustration, PlanB one-step emergency contraceptive is displayed on June 30, 2022 in San Anselmo, California. Justin Sullivan | Getty Images The Food and Drug Administration is changing the informational packaging of the emergency contraceptive pill, Plan B One-Step, to clarify that it is not an abortion pill, the federal agency announced Friday. … Read more

Kala Pharmaceuticals shares soar after FDA approves trial for drug to treat PCED

Shares of Kala Pharmaceuticals surged Wednesday after the small biotechnology company announced a drug candidate for a rare eye disease. The Food and Drug Administration has accepted Kala’s investigational drug application for KPI-012, a potential treatment for persistent corneal epithelial defect, or PCED, the Arlington, Massachusetts-based company announced on Tuesday.  Kala shares soared $9.45, or … Read more

QURE Stock Rockets After FDA Approves Its Most Expensive Drug Ever

The Food and Drug Administration just approved its most expensive drug ever — a hemophilia gene therapy from Carlisle Companies (CSL) and UniQure (QURE) — and QURE stock popped Wednesday. X The infusion is approved for hemophilia B patients currently on a prevention regimen called Factor IX therapy, or who have a history of potentially … Read more

FDA approves most expensive drug ever, $3.5 million-per-dose gene therapy for hemophilia B

Washington — U.S. health regulators on Tuesday approved the first gene therapy for hemophilia, a $3.5 million one-time treatment for the blood-clotting disorder. The Food and Drug Administration cleared Hemgenix, an IV treatment for adults with hemophilia B, the less common form of the genetic disorder which primarily affects men. Currently, patients receive frequent, expensive IVs … Read more

Philips recall woes grow as it flags new concerns with FDA over replaced ventilators

mekcar Philips (NYSE:PHG), which has been mired with recall of its respiratory devices, informed the the U.S. Food and Drug Administration (FDA) that its Respironics Trilogy ventilators reworked as a part of a June 2021 recall have two new potential issues. The FDA said on Nov. 17 that the first issue was that the new … Read more

Using an Online Pharmacy to Buy Meds? It’s Buyer Beware, FDA Says

By Cara Murez  HealthDay Reporter FRIDAY, Nov. 18, 2022 (HealthDay News) — It might be tempting to buy prescription medication online, but buyers should beware, the U.S. Food and Drug Administration warns. While some pharmacy websites operate legally and can offer convenience, privacy and lower costs, others may be selling unapproved, counterfeit and unsafe medications, … Read more

MacroGenics to get $60M milestone from Provention as FDA approves diabetes drug Tzield

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. Is this happening to you frequently? Please report it on our feedback forum. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. Source link